KRAS and neoplasm: Finally, it was interesting to observe that among KRAS-mutated samples, three distinct groups with different FAL frequencies can easily be distinguished (Figure 3B), and it will be interesting to further investigate whether the three groups are associated with a different clinical courses and whether the group with the highest FAL (group 1) is also characterized by a high tumor mutational burden.